Paper 42 - HISTOLOGY AND MALIGNANCY GRADE ACCURACY OF PREOPERATIVE BIOPSY OF PRIMARY RETROPERITONEAL SARCOMA. A STUDY FROM THE TRANSATLANTIC AUSTRALASIAN RETROPERITONEAL SARCOMA WORKING GROUP (TARPSWG)

Author(s)

• 

  Alessandra Borghi, MD

  Surgeon
  Fondazione IRCCS Istituto Nazionale dei Tumori
  Milan, Lombardia, Italy

  Slides

Co-Author(s)

• 

  Marco Fiore, MD, FACS, FEBS

  Surgeon
  Fondazione IRCCS Istituto Nazionale dei Tumori
  Milano, Lombardia, Italy
• DS

  Dirk Strauss, MD

  The Royal Marsden Hospital
  London, England, United Kingdom
• SB

  Sylvie Bonvalot, MD

  Institut Curie
  Paris, Ile-de-France, France
• CR

  Chandrajit P. Raut, MD, MSc

  Chief, Division of Surgical Oncology (BWH) and Chair, Department of Surgery (DFCI)
  Brigham and Women’s Hospital, Dana-Farber Cancer Institute, Harvard Medical School
  Boston, Massachusetts, United States
• PR

  Piotr Ł. Rutkowski, Professor, MD, PhD

  Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw Poland
  Warsaw, Mazowieckie, Poland
• 

  Samuel Ford, PhD, FRCS

  Consultant Sarcoma Surgeon
  Queen Elizabeth Hospital
  Birmingham, England, United Kingdom
• CS

  Carol J. Swallow, MD, PhD

  Surgical Oncologist
  Princess Margaret Cancer Centre, University Health Network and Mount Sinai Hospital
  Toronto, Ontario, Canada
• 

  David E. Gyorki, MBBS MD FRACS

  Surgical Oncologist
  Peter MacCallum Cancer Centre
  Melbourne, Australia, Victoria, Australia
• 

  Markus Albertsmeier, MD

  Attending Surgeon
  LMU Hospital, Ludwigs-Maximilians-Universität Munich
  Munich, Bayern, Germany
• FC

  Ferdinando CM Cananzi, MD

  IRCCS Humanitas Research Hospital
  Rozzano, Milan, Lombardia, Italy
• KC

  Kenneth Cardona, MD

  Winship Cancer Institute
  Atlanta, Georgia, United States
• 

  Carolyn Nessim, MD, MSc, FRCSC, FACS (she/her/hers)

  Surgical Oncologist
  Ottawa Hospital Research Institute
  Ottawa, Ontario, Canada
• 

  Valerie Grignol, MD (she/her/hers)

  Associate Professor of Surgery
  The Ohio State University James Cancer Hospital
  Columbus, Ohio, United States
• EP

  Elisabetta Pennacchioli, MD

  Istituto Europeo di Oncologia
  Milan, Lombardia, Italy
• MN

  Marko Novak, MD

  Institute of Oncology Ljubljana
  Ljubljana, Ljubljana, Slovenia
• 

  Shintaro Iwata, MD (he/him/his)

  Assistant Chief
  National Cancer Center Hospital Japan
  Tokyo, Tokyo, Japan
• GT

  Gabriele Tinè, MD

  Istituto Nazionale Tumori, Milan, Italy
  Milan, Lombardia, Italy
• 

  Daniela Salvatore, PhD

  Clinical Research Coordinator
  Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
  Milano, Lombardia, Italy
• ED

  Elena Di Blasi, MD

  Fondazione IRCCS Istituto Nazionale dei Tumori
  Milan, Lombardia, Italy
• MW

  Michelle Jennifer Wilkinson, FRCS, PhD

  Ms
  The Royal Marsden Hospital
  London, England, United Kingdom
• DT

  Dimitrios Tzanis, MD, PhD

  Institut Curie
  Paris, Ile-de-France, France
• 

  Jiping Wang, MD, PhD (he/him/his)

  Associate Professor of Surgery
  Brigham and Women's Hospital
  Boston, Massachusetts, United States
• JS

  Jacek Skoczylas, MD

  Maria Sklodowska-Curie National Research Institute of Oncology
  Warsaw, Mazowieckie, Poland
• mA

  max Almond, FRCS

  Consultant Sarcoma Surgeon
  Queen Elizabeth Hospital Birmingham
  BIRMINGHAM, England, United Kingdom
• RG

  Rebecca Gladdy, n/a

  Mount Sinai Hospital
  Toronto, Ontario, Canada
• 

  Catherine Mitchell, MBBS FRCPA

  Pathologist
  Peter MacCallum Cancer Centre
  Melbourne, Victoria, Australia
• AH

  Andrew J. Hayes, MD PhD

  Prof
  Royal Mardsen Hospital
  London, England, United Kingdom
• 

  Rosalba Miceli, PhD (she/her/hers)

  Head of the Biostatistics for Clinical Research Unit
  Fondazione IRCCS Istituto Nazionale dei Tumori
  Milan, Lombardia, Italy
• 

  Alessandro Gronchi, MD, FSSO (he/him/his)

  Chief of Sarcoma Service and Chair of the Department of Surgery
  Fondazione IRCCS Istituto Nazionale dei Tumori
  Milan, Lombardia, Italy